Technical Analysis for AGL - Angle Plc

Grade Last Price % Change Price Change
B 121.0 -0.82% -1.00
AGL closed down 2.01 percent on Tuesday, January 25, 2022, on 2.74 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Down
Historical AGL trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish -0.82%
Cup with Handle Other -0.82%
Down 3 Days in a Row Weakness -0.82%
Down 4 Days in a Row Weakness -0.82%
MACD Bearish Centerline Cross Bearish -2.81%
20 DMA Support Bullish -2.81%
Cup with Handle Other -2.81%
Overbought Stochastic Strength -2.81%
Down 3 Days in a Row Weakness -2.81%
50 DMA Resistance Bearish -4.35%
Older End-of-Day Signals for AGL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
200 DMA Support 20 minutes ago
Fell Below Previous Day's Low about 2 hours ago
Down 1% about 2 hours ago
Fell Below 200 DMA about 2 hours ago
Possible NR7 about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Angle Plc Description

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Monitoring Cancer Medical Specialties Nature Oncology Fluid Clinical Medicine Offers Products Blood Tumor Drug Development Medical Diagnostic Circulating Tumor Cell

Is AGL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 144.0
52 Week Low 64.25
Average Volume 633,317
200-Day Moving Average 120.97
50-Day Moving Average 127.61
20-Day Moving Average 122.60
10-Day Moving Average 124.45
Average True Range 4.15
ADX 15.27
+DI 24.43
-DI 29.76
Chandelier Exit (Long, 3 ATRs) 119.56
Chandelier Exit (Short, 3 ATRs) 118.19
Upper Bollinger Bands 128.42
Lower Bollinger Band 116.78
Percent B (%b) 0.45
BandWidth 9.49
MACD Line -0.23
MACD Signal Line -0.69
MACD Histogram 0.4552
Fundamentals Value
Market Cap 262.79 Million
Num Shares 215 Million
EPS -6.60
Price-to-Earnings (P/E) Ratio -18.48
Price-to-Sales 76.32
Price-to-Book 3.39
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 127.10
Resistance 3 (R3) 127.33 125.87 126.25
Resistance 2 (R2) 125.87 124.57 125.75 125.97
Resistance 1 (R1) 123.93 123.77 123.20 123.70 125.68
Pivot Point 122.47 122.47 122.10 122.35 122.47
Support 1 (S1) 120.53 121.17 119.80 120.30 118.32
Support 2 (S2) 119.07 120.37 118.95 118.03
Support 3 (S3) 117.13 119.07 117.75
Support 4 (S4) 116.90